|
NVRO
|
Nevro Corp.
|
0.39%
|
US
|
NYSE
|
|
CTKB
|
Cytek Biosciences, Inc.
|
0.39%
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
ATEC
|
Alphatec Holdings, Inc.
|
0.37%
|
US
|
NASDAQ
|
|
TMCI
|
Treace Medical Concepts, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
0.36%
|
US
|
NASDAQ
|
|
MNKD
|
MannKind Corporation
|
0.36%
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
0.35%
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
0.34%
|
US
|
NASDAQ
|
|
NEO
|
NeoGenomics, Inc.
|
0.34%
|
US
|
NASDAQ
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
0.33%
|
US
|
NASDAQ
|
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.33%
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
0.32%
|
US
|
NASDAQ
|
|
VCEL
|
Vericel Corporation
|
0.31%
|
US
|
NASDAQ
|
|
SAVA
|
Cassava Sciences, Inc.
|
0.31%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
0.31%
|
US
|
NASDAQ
|
|
ACRS
|
Aclaris Therapeutics, Inc.
|
0.31%
|
US
|
NASDAQ
|
|
VRDN
|
Viridian Therapeutics, Inc.
|
0.30%
|
US
|
NASDAQ
|